Board of Directors
Chairman of the Board
Beth Everett, Ph.D.
AVP Business Consulting & Technology Services, SAIC
Vice Chairman of the Board
Andrew Jacobson, Ph.D.
Chair, LSIT Technology Advisory Board (TAB)
Board Members:
Paul Allen
Managing Partner, Life Sciences, Clarkston Consulting
Anette Asher
President and CEO, LSIT Global Institute
Greg Caressi
Senior Vice President, Healthcare & Life Sciences, Frost & Sullivan
Alan Edwards
Senior Director, Americas Product Group, Scientific for Kelly Services, Inc.
Steven Fouskarinis
LSIT Recording Secretary
Go Team
Charles Jaffe, MD, PhD, FACMI
Chief Executive Officer, Health Level 7 (HL7)
Howard R. Asher
President, CEO, Global Life Sciences, Inc.
Founder, Chairman of the Board 2003~2005, LSIT Global Institute
Paul Laskin
CIO & Co-Founder, Cirrhus9
Gerry Martin
Ret. Vice President, Abbott Laboratories
Jonathan Morris, M.D.
CEO, ProSanos Corporation
Geoffrey Odell
Vice President & Global Head - Development IT, Novartis Pharmaceuticals Corporation
Chairman of the Board 2005~2007, LSIT Global Institute
Terry L. Schmidt DrHA
Healthcare Executive
Andy Spinks
Director, Pfizer
Research & Development and Medical Informatics - RDMi Americas Region
Ford Winslow
Treasurer, LSIT
Technology Advisory Board - Director of Process
Chair (Interim), LSIT Industry Advisory Board
Go Team
CIO, Abnology, Inc.
About the Board
All activities of the LSIT Global Institute are managed by a Board of Directors. Directors are selected for their expertise in IT, the life sciences and regulatory affairs. Directors serve two-year, staggered terms. They have final authority over all Institute business, hire and supervise the executive staff (a president, a secretary/treasurer, and other staff members as needed), and control the budget. The Board of Directors appoints individuals to serve on the Technology Advisory Board. The daily affairs of the Institute will be conducted by the President, who supervises the initiatives and is responsible to the Board of Directors for the Institute's performance.
